You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

R132

Showing 1 - 25 of 3,005
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Glioma Trial in Germany (IDH1R132H peptide vaccine, Avelumab)

Recruiting
  • Malignant Glioma
  • Berlin, Germany
  • +9 more
Feb 1, 2022

Advanced Malignancies That Harbor IDHR132 Mutations Trial in Worldwide (IDH305)

Active, not recruiting
  • Advanced Malignancies That Harbor IDHR132 Mutations
  • Boston, Massachusetts
  • +12 more
Dec 9, 2021

Acne Vulgaris Trial in Belgium, Canada, United States (IDP-126 Gel, IDP-126 Vehicle Gel, Epiduo® Forte Gel)

Active, not recruiting
  • Acne Vulgaris
  • IDP-126 Gel
  • +2 more
  • Bryant, Arkansas
  • +41 more
Jul 13, 2022

Triple Negative Breast Cancer, PD-L1 Positive Trial in Puerto Rico, United States (Sacituzumab Govitecan-hziy, Pembrolizumab,

Recruiting
  • Triple Negative Breast Cancer
  • PD-L1 Positive
  • Sacituzumab Govitecan-hziy
  • +5 more
  • Anchorage, Alaska
  • +245 more
Jan 12, 2023

Chronic Plaque Psoriasis Trial in Canada, United States (Topical roflumilast)

Enrolling by invitation
  • Chronic Plaque Psoriasis
  • Topical roflumilast
  • Beverly Hills, California
  • +68 more
Nov 9, 2022

Atopic Dermatitis Eczema Trial in Canada, United States (ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%)

Recruiting
  • Atopic Dermatitis Eczema
  • ARQ-151 Cream 0.15% or ARQ-151 Cream 0.05%
  • Birmingham, Alabama
  • +91 more
Jan 26, 2023

Glioma Trial in Germany (IDH1 peptide vaccine)

Completed
  • Glioma
  • IDH1 peptide vaccine
  • Berlin, Germany
  • +7 more
Nov 6, 2018

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Insulin Glargine 100U/mL, Insulin Degludec)

Completed
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +3 more
  • Birmingham, Alabama
  • +178 more
Nov 3, 2022

Moderate to Severe Atopic Dermatitis Trial in Worldwide (ISB 830 - Part 1 Group 1, ISB 830 - Part 1 Group 2, ISB 830 - Part 1

Completed
Has Results
  • Moderate to Severe Atopic Dermatitis
  • ISB 830 - Part 1 Group 1
  • +5 more
  • Birmingham, Alabama
  • +82 more
Jul 26, 2022

Glioma Trial in Tokyo (DS-1001b)

Active, not recruiting
  • Glioma
  • Tokyo, Japan
    National Cancer Center Hospital
Feb 2, 2022

Type 2 Diabetes Trial in Worldwide (Tirzepatide, Insulin Degludec)

Completed
Has Results
  • Type 2 Diabetes Mellitus
  • Little Rock, Arkansas
  • +121 more
Jan 14, 2022

Ovarian Carcinoma Trial in New Haven (Sacituzumab govitecan)

Not yet recruiting
  • Ovarian Carcinoma
  • Sacituzumab govitecan
  • New Haven, Connecticut
    Smilow Cancer Hospital at Yale New Haven
Aug 31, 2023

Diabetes, Type 2 Trial in Worldwide (Insulin icodec, Placebo (insulin 287), Metformin)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Insulin icodec
  • +5 more
  • Lancaster, California
  • +48 more
Mar 5, 2021

Cervical Cancer Trial (Sacituzumab Govitecan)

Not yet recruiting
  • Cervical Cancer
  • Sacituzumab Govitecan
  • (no location specified)
Apr 18, 2023

NSCLC Trial in Worldwide (Sacituzumab Govitecan-hziy (SG), Docetaxel)

Recruiting
  • Non-Small Cell Lung Cancer
  • Anchorage, Alaska
  • +104 more
Jul 20, 2022

Advanced or Metastatic Solid Tumor, Liver Failure Trial in United States (Sacituzumab Govitecan-hziy)

Recruiting
  • Advanced or Metastatic Solid Tumor
  • Liver Failure
  • Sacituzumab Govitecan-hziy
  • Long Beach, California
  • +5 more
Jan 6, 2023

Candidates for Neoadjuvant Treatment in Resectable Pancreatic

Completed
  • Pancreatic Cancer
  • Neoadjuvant
  • Neoadjuvant treatment
  • (no location specified)
Nov 9, 2023

Leukemia, Myeloid, Acute Trial in Germany, United States (BAY1436032)

Completed
  • Leukemia, Myeloid, Acute
  • Bronx, New York
  • +12 more
May 13, 2019

Nasal Bleeding Trial in Cairo (Epinephrine Inhalation Solution)

Completed
  • Nasal Bleeding
  • Epinephrine Inhalation Solution
  • Cairo, Egypt
    Ain Shams University Hospital
Feb 12, 2023

Locally Advanced or Metastatic Unresectable Urothelial Cancer Trial in Worldwide (Sacituzumab Govitecan-hziy, Paclitaxel,

Recruiting
  • Locally Advanced or Metastatic Unresectable Urothelial Cancer
  • Sacituzumab Govitecan-hziy
  • +3 more
  • Phoenix, Arizona
  • +210 more
Jul 28, 2022

Aging, Physical Activity, Cognitive Function Trial in Calgary (Aerobic exercise)

Recruiting
  • Aging
  • +2 more
  • Aerobic exercise
  • Calgary, Alberta, Canada
    University of Calgary
Nov 2, 2022

Clinical Evaluation of Genetron IDH1 PCR Kit in Glioma Patients

Completed
  • Glioma, Malignant
  • Glioma, Mixed
    • Jilin, China
    • +3 more
    Nov 12, 2021

    Idiopathic Pulmonary Fibrosis Trial in Birmingham (Venetoclax)

    Not yet recruiting
    • Idiopathic Pulmonary Fibrosis
    • Birmingham, Alabama
      A. Brent Carter
    Aug 3, 2023

    Preoperative Magnetic Detection of Non-palpable Breast Lesions

    Active, not recruiting
    • Breast Diseases
    • Breast Cancer
      • Paris, France
        Groupe Hospitalier Paris Saint-Joseph
      Oct 31, 2022

      Dermatitis Herpetiformis Trial in Tampere (Assessment of prognosis of refractory dermatitis herpetiformis. No intervention)

      Enrolling by invitation
      • Dermatitis Herpetiformis
      • Assessment of prognosis of refractory dermatitis herpetiformis. No intervention
      • Tampere, Finland
        Tampere University Hospital
      Aug 18, 2023